Standardized Oral Care for Premature Infant Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the best oral care method for premature infants with very low birth weight (VLBW) to prevent complications. Researchers will compare two groups: one receiving frequent standardized oral care every 3-4 hours and another every 12 hours. They seek to identify which method better supports the babies' health, particularly in reducing lung issues like pneumonia. The study will track changes in the infants' mouth bacteria and their need for breathing support. Babies born before 32 weeks and weighing less than 1500 grams may be eligible to join. As an unphased trial, this study provides a unique opportunity to contribute to vital research that could improve care for vulnerable infants.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that this oral care protocol is safe for premature infants?
Research has shown that regular oral care can benefit premature babies. A review of five studies found that oral care promotes a healthier balance of bacteria in the mouths and airways of very sick infants. This balance may prevent the growth of harmful bacteria, potentially reducing infections.
The reviewed studies did not report any major harm from regular oral care, indicating it is generally safe. However, each baby may react differently, so careful monitoring remains essential.
The current trial is not in a phase that typically tests safety, so direct evidence on possible risks is limited. Nonetheless, positive results from other studies suggest that regular oral care is likely safe for premature babies.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how the frequency of oral care might impact the health of premature infants. Unlike the standard practice that involves less frequent oral care, this trial investigates the effects of providing oral care every 3-4 hours. The goal is to determine if more frequent oral hygiene can better prevent infections and improve overall health outcomes in these vulnerable newborns. By examining these variations in care frequency, researchers hope to identify a more effective routine that could become a new standard in neonatal care.
What evidence suggests that frequent standardized oral care is effective for premature infants?
Research has shown that regular oral care can help balance bacteria in the mouth. In very sick adults, maintaining this balance can prevent issues like infections. Although data for very low birth weight (VLBW) infants is not yet available, this method is expected to benefit them as well by targeting the same harmful bacteria. Early results suggest that frequent oral care might improve the health of VLBW infants by reducing the risk of breathing problems and infections. In this trial, infants will receive standardized oral care either every 12 hours or every 3-4 hours. This is crucial because a healthy mouth can lead to better breathing and feeding, which are vital for preterm babies.13567
Who Is on the Research Team?
Leslie Parker
Principal Investigator
University of Florida
Are You a Good Fit for This Trial?
This trial is for premature infants with a birth weight under 1500 grams and gestational age less than 32 weeks. Their mothers must be English-speaking adults over 18 years old. Infants with facial, lung, or gastrointestinal anomalies or those not expected to survive are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants receive standardized oral care every 3-4 hours or every 12 hours for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Frequent Standardized Oral Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor